(Q42560878)

2 November 2017

0 references

Inhibitory short synthetic oligodeoxynucleotides and lupus (English)

1 reference

2 November 2017

2

1 reference

2 November 2017

Zheng Liu

1

1 reference

2 November 2017

26 June 2009

1 reference

Arthritis Research and Therapy

2 November 2017

1 reference

2 November 2017

11

1 reference

2 November 2017

3

1 reference

2 November 2017

116

1 reference

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Development of TLR inhibitors for the treatment of autoimmune diseases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

Toll-like receptor control of the adaptive immune responses

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2714142

The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo

28 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19591639

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19591639

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/AR2726

1 reference

PMC publication ID

2714142

Dimensions Publication ID

2 November 2017

0 references

1 reference

PMC publication ID

2714142

2 November 2017

PubMed publication ID

19591639

1 reference

PMC publication ID

2714142